PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation

Name: PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation
Creator: Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310029, China.
Published: 2025-03-01T16:05:03+08:00